Amani Therapeutics, Inc., 2025-12-10
An SEC Form D private-offering notice from New York, NY, a $31,120,000 filer-stated offering target in Biotech. Filed 2025-12-10. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Biotech developing AM-01, a fixed dose combination therapy pairing clozapine with a novel compound to treat treatment resistant schizophrenia.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- General Services Holdings of New York, Inc., 2025-12-11, $130K, Brooklyn, NY
- Bala Enzyme Inc., 2025-12-11, $1.4M, Seal Beach, CA
- Vcapcoin INC, 2025-12-11, $9M, New York, NY
- Cellphire, Inc., 2025-12-11, $3M, Rockville, MD
- Leaselot, Inc., 2025-12-11, $15M, New York, NY
- Oncotelic Therapeutics, Inc., 2025-12-11, $12.5M, Agoura Hills, CA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.